Follow
J. Jack Lee
J. Jack Lee
University of Texas M.D. Anderson Cancer Center
Verified email at mdanderson.org
Title
Cited by
Cited by
Year
Comprehensive genomic characterization of head and neck squamous cell carcinomas.
JJ Lee
Nature 517 (7536), 576-82, 2015
31842015
Prostate cancer radiation dose response: results of the MD Anderson phase III randomized trial
A Pollack, GK Zagars, G Starkschall, JA Antolak, JJ Lee, E Huang, ...
International Journal of Radiation Oncology* Biology* Physics 53 (5), 1097-1105, 2002
17492002
Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients
JE Gershenwald, W Thompson, PF Mansfield, JE Lee, MI Colome, ...
Journal of clinical oncology 17 (3), 976-976, 1999
14301999
The BATTLE trial: personalizing therapy for lung cancer
ES Kim, RS Herbst, II Wistuba, JJ Lee, GR Blumenschein Jr, A Tsao, ...
Cancer discovery 1 (1), 44-53, 2011
10182011
Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.
JA Roth, D Nguyen, DD Lawrence, BL Kemp, CH Carrasco, DZ Ferson, ...
Nature medicine 2 (9), 985-991, 1996
10091996
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing
J Zhang, J Fujimoto, J Zhang, DC Wedge, X Song, J Zhang, S Seth, ...
Science 346 (6206), 256-259, 2014
10062014
An epithelial–mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor …
LA Byers, L Diao, J Wang, P Saintigny, L Girard, M Peyton, L Shen, Y Fan, ...
Clinical cancer research 19 (1), 279-290, 2013
9962013
bcl-2 and p53 Oncoprotein Expression during Colorectal Tumorigenesis
FA Sinicrope, SB Ruan, KR Cleary, LC Stephens, JJ Lee, B Levin
Cancer research 55 (2), 237-241, 1995
9371995
Dose escalation methods in phase I cancer clinical trials
C Le Tourneau, JJ Lee, LL Siu
JNCI: Journal of the National Cancer Institute 101 (10), 708-720, 2009
9302009
Surgical treatment of multiple brain metastases
RK Bindal, R Sawaya, ME Leavens, JJ Lee
Journal of neurosurgery 79 (2), 210-216, 1993
7271993
Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine …
RS Herbst, DH Johnson, E Mininberg, DP Carbone, T Henderson, ES Kim, ...
Journal of Clinical Oncology 23 (11), 2544-2555, 2005
7012005
Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer
A Pollack, GK Zagars, LG Smith, JJ Lee, AC Von Eschenbach, JA Antolak, ...
Journal of clinical oncology 18 (23), 3904-3911, 2000
6692000
Bayesian adaptive methods for clinical trials
SM Berry, BP Carlin, JJ Lee, P Muller
CRC press, 2010
6662010
Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer
SG Swisher, JA Roth, J Nemunaitis, DD Lawrence, BL Kemp, ...
Journal of the National Cancer Institute 91 (9), 763-771, 1999
6511999
Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.
JE Gershenwald, MI Colome, JE Lee, PF Mansfield, C Tseng, JJ Lee, ...
Journal of clinical oncology 16 (6), 2253-2260, 1998
6201998
Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer
FR Khuri, H Wu, JJ Lee, BL Kemp, R Lotan, SM Lippman, L Feng, ...
Clinical cancer research 7 (4), 861-867, 2001
5982001
Predicting cancer development in oral leukoplakia: ten years of translational research
JJ Lee, WK Hong, WN Hittelman, L Mao, R Lotan, DM Shin, SE Benner, ...
Clinical Cancer Research 6 (5), 1702-1710, 2000
5902000
Clonal genetic alterations in the lungs of current and former smokers
L Mao, JS Lee, JM Kurie, YH Fan, SM Lippman, A Broxson, FR Khuri, ...
Journal of the National Cancer Institute 89 (12), 857-862, 1997
5701997
Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome
NT Ihle, LA Byers, ES Kim, P Saintigny, JJ Lee, GR Blumenschein, A Tsao, ...
Journal of the National Cancer Institute 104 (3), 228-239, 2012
5512012
PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations
F Janku, JJ Wheler, SN Westin, SL Moulder, A Naing, AM Tsimberidou, ...
Journal of clinical oncology 30 (8), 777, 2012
5152012
The system can't perform the operation now. Try again later.
Articles 1–20